Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price traded down 2.9% during trading on Thursday . The stock traded as low as $0.9668 and last traded at $0.9708. 581,510 shares changed hands during trading, an increase of 767% from the average session volume of 67,097 shares. The stock had previously closed at $1.00.
Cardiol Therapeutics Price Performance
The stock’s fifty day moving average is $1.01 and its two-hundred day moving average is $1.05.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- Elon Musk’s $1 Quadrillion AI IPO
- Silver paying 20% dividend. Plus 68% share gains
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Look who’s buying 2 tonnes of gold… per week!
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
